STOCK TITAN

Neolara (NELR) Stock Price, News & Analysis

NELR OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
11 16 sessions, June 29, 2026 to August 19, 2026
Largest daily move
+363.6% close of July 17, 2026
1-month change
+390.2% closing prices, July 17, 2026 to August 19, 2026

Company Description

Neolara Corp (symbol: NELR) is a corporation incorporated in the U.S. state of Wyoming, as disclosed in its reports filed under the Securities Exchange Act of 1934. According to an 8-K filed with the U.S. Securities and Exchange Commission, the company has a Commission File Number of 000-56687 and an Internal Revenue Service employer identification number of 98-1674969. While recent filings describe important corporate governance changes, they do not provide a detailed description of Neolara Corp’s operating business or industry classification.

The same 8-K filing lists a mailing location in Coto Brus, Puntarenas, Costa Rica, indicating that Neolara Corp maintains a connection to that region for corporate correspondence. However, the filing focuses on ownership and management changes rather than operational activities, and it does not specify the company’s sector, products, or services. As a result, publicly available regulatory information emphasizes Neolara Corp’s corporate structure and control rather than its day-to-day commercial operations.

Corporate control and governance

According to the 8-K dated September 19, 2025, a stock purchase agreement resulted in a change in control of Neolara Corp. The previous chief executive officer, director, and majority shareholder entered into an agreement to sell 2,000,000 shares of common stock, representing approximately 63% of the issued and outstanding common shares as of that date, to a new controlling shareholder, Cao Wei. This share transfer gives the buyer the ability to unilaterally influence the election of the board of directors and other matters requiring shareholder approval.

The same filing states that, effective on the date of the transaction, the prior executive officers and directors resigned from their positions, including roles such as Chief Executive Officer and President, and as members of the board. On that date, Cao Wei was appointed as Chief Executive Officer, Chief Financial Officer, Secretary, and sole Director of Neolara Corp. These disclosures highlight that the company’s governance is concentrated in a single individual following the reported change in control.

Board composition and professional backgrounds

The 8-K filing also provides background information about individuals associated with the board and management. It describes Cao Wei’s prior experience in architectural design and construction-related roles at several companies, as well as his Bachelor of Civil Engineering degree from Hubei University of Technology. This indicates that the controlling officer and director has a professional history in civil engineering and construction design.

In addition, the filing describes Li Yan as a director with experience in biomedical engineering roles, including positions focused on clinical validation of medical devices, product development, and technical support. Li Yan holds a Bachelor’s degree in Biomedical Engineering from Hubei University of Science and Technology. Another director, Lloveras Amador Ricardo, is described as having experience in software development and project management, including work on web applications, automated testing frameworks, and large-scale IT projects. He holds a Bachelor’s degree in Computer Engineering from the University of Barcelona.

These biographies show that Neolara Corp’s leadership and board-level participants have backgrounds spanning civil engineering, biomedical engineering, and software development. However, the 8-K does not state that Neolara Corp itself operates in these fields; it only documents the prior careers and education of the individuals involved.

Regulatory reporting and public company status

Neolara Corp files reports with the SEC under the Securities Exchange Act of 1934, as evidenced by the 8-K reports describing changes in control and management. The presence of a Commission File Number and the use of standard SEC item headings (such as Item 5.01 and Item 5.02) indicate that Neolara Corp is subject to ongoing reporting obligations. The filings focus on material events related to ownership and governance, which are key areas of interest for investors evaluating corporate control and board oversight.

Because the available filings do not describe the company’s revenue sources, business segments, or specific industry, investors researching Neolara Corp may rely heavily on these governance disclosures to understand who directs the company and how control is exercised. The concentration of ownership and management in a small group of individuals is a notable feature of the company’s current structure, as described in the 8-K.

Information limitations

Based on the information provided in recent SEC filings, Neolara Corp’s detailed business activities, sector classification, and product or service offerings are not specified. The filings instead emphasize corporate control, board composition, and the professional backgrounds of key individuals. As a result, any assessment of Neolara Corp using public regulatory documents will focus primarily on its status as a Wyoming corporation with a documented change in control and a board and management team whose experience spans engineering and software disciplines.

Prospective investors and researchers can use this information to understand the company’s legal jurisdiction of incorporation, the extent of ownership concentration, and the qualifications of its leadership, while recognizing that additional sources would be needed to obtain a full picture of Neolara Corp’s operational business model.

Stock Performance

$0.0250
No recent trading
Last close: August 19, 2026
+390.2%
1 month to August 19, 2026

Neolara (NELR) closed at $0.0250 on August 19, 2026. In the month to August 19, 2026, the price gained 390.2%.

See what a $1,000 investment in NELR would be worth today

Average down calculator for NELR

NELR Metrics & Rankings

Price returns through August 19, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for NELR.

Financial Highlights

Neolara generated $29K in revenue in FY2025, retaining a 76.4% gross margin, and net income was -$24K, reflecting a -81.3% net profit margin. The company generated -$41K in operating cash flow.

$29K
Revenue (FY2025)
-$24K
Net Income (FY2025)
-$41K
Operating Cash Flow
$22K
Gross Profit (FY2025)

Upcoming Events

No upcoming events scheduled for NELR.

Frequently Asked Questions

Neolara (NELR) has no recent trading. Its last close was $0.0250 on August 19, 2026.

The FY2025 revenue of Neolara (NELR) is $29K, from its most recent completed fiscal year.

The FY2025 net income of Neolara (NELR) is -$24K, from its most recent completed fiscal year.

The operating cash flow of Neolara (NELR) is -$41K for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Neolara (NELR) is -81.3% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The gross profit margin of Neolara (NELR) is 76.4% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The gross profit of Neolara (NELR) is $22K for FY2025, its most recent completed fiscal year.

Neolara Corp is a corporation incorporated in Wyoming with a Commission File Number 000-56687, as disclosed in its SEC filings. Recent reports focus on changes in control and management rather than describing a specific operating business or industry.

According to its 8-K filing, Neolara Corp is incorporated in the state of Wyoming in the United States. This jurisdiction is listed in the filing’s table of corporate information.

An 8-K dated September 19, 2025 reports a stock purchase agreement in which the previous majority shareholder sold 2,000,000 shares of common stock, representing approximately 63% of the outstanding common shares, resulting in a change in control of Neolara Corp.

The 8-K states that Cao Wei purchased 2,000,000 shares of Neolara Corp’s common stock, representing about 63% of the issued and outstanding shares as of that date, giving him the ability to unilaterally control board elections and other matters requiring shareholder approval.

The same 8-K reports that the prior executive officers and directors resigned from all executive positions and board roles, and that Cao Wei was appointed Chief Executive Officer, Chief Financial Officer, Secretary, and sole Director effective on the date of the transaction.

The 8-K describes Cao Wei as having experience in architectural design and construction roles and holding a Bachelor of Civil Engineering. It also notes that Li Yan has a background in biomedical engineering and that Lloveras Amador Ricardo has experience in software development and IT project management, each with relevant engineering degrees.

The 8-K filing detailing the change in control does not specify Neolara Corp’s industry, business segments, or main products or services. It focuses on ownership, governance changes, and the professional histories of officers and directors.

By filing an 8-K under the Securities Exchange Act of 1934 and listing a Commission File Number, Neolara Corp indicates that it is an SEC-reporting company subject to ongoing disclosure requirements for material events such as changes in control and management.